Trials / Unknown
UnknownNCT02385656
The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Open-pilot study for the efficacy and tolerability of modafinil on the fatigue and somnolence in cancer-patients.
Detailed description
This is an open-pilot study for the efficacy and tolerability of modafinil on the fatigue and somnolence in cancer-patients. Patients with moderate to severe cancer-related fatigue will be treated with modafinil for 4 weeks and psychological tests including self-questionnaire, cognitive test, sleep-wake cycle, quantitative electroencephalogram(QEEG) will be applied pre- and post-treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Modafinil | 200mg of modafinil daily for 4 weeks |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2015-03-11
- Last updated
- 2015-03-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02385656. Inclusion in this directory is not an endorsement.